Shareholders investing on the back of US FDA approvals coming...

Shareholders investing on the back of US FDA approvals coming through would be wise to pop over to OBJ and AVH threads for some broad research on the dangers of depending on such a specific outcome. Most notable both of those deal with skin based applications, far simpler and more easily measurable risks than than this.

When I see an international, unproven technology listing on the ASX I always first ask myself,
- Why didn't they list this closer to home? (West Australian based internationals are a particular red flag for me personally)

With $3m cash I'm afraid there is a lot of pain to come; and if history is any guide it will be for years.
Look deeply into your director and management histories is my best advice.
Lots of red flags here, personally I'm more inclined to wait for more solid revnue and success signal than NTI has. IMHO.